 |
|
Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study
Hye Jin Chang, Jung Ryeol Lee, Byung Chul Jee, Chang Suk Suh, Won Don Lee, Seok Hyun Kim
Clin Exp Reprod Med. 2013;40(2):83-89. Published online 2013 Jun 30 DOI: https://doi.org/10.5653/cerm.2013.40.2.83
|
|
Citations to this article as recorded by
 A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial
Bei Xu, Dirk Geerts, Jiaying Yuan, Mengting Wang, Zhou Li, Qiaohong Lai, Yu Zheng, Si Liu, Shulin Yang, Guijin Zhu, Lei Jin
Human Reproduction.2024;[Epub] CrossRef Discovery of the thieno[2,3-d]pyrimidine-2,4-dione derivative 21a: A potent and orally bioavailable gonadotropin-releasing hormone receptor antagonist
Fangxia Zou, Yao Wang, Dawei Yu, Chunjiao Liu, Jing Lu, Min Zhao, Mingxu Ma, Wenyan Wang, Wanglin Jiang, Yonglin Gao, Rui Zhang, Jianzhao Zhang, Liang Ye, Jingwei Tian
European Journal of Medicinal Chemistry.2022; 242: 114679. CrossRef Discovery of the Thieno[2,3-d]Pyrimidine-2,4-Dione Derivative 21a: A Potent and Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist
Fangxia Zou, Yao Wang, Dawei Yu, Chunjiao Liu, Jing Lu, Min Zhao, Mingxu Ma, Wenyan Wang, Wanglin Jiang, Yonglin Gao, Rui Zhang, Jianzhao Zhang, Liang Ye, Jingwei Tian
SSRN Electronic Journal .2022;[Epub] CrossRef GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve
Huihui Xu, Shen Zhao, Xinxing Gao, Xian Wu, Lan Xia, Dan Zhang, Jian Li, Aijun Zhang, Bufang Xu
Frontiers in Endocrinology.2021;[Epub] CrossRef
|